Sorrento Therapeutics, the California-based biopharmaceutical company, claims to have developed an antibody that can protect cells from coronavirus infection and eliminate it from the body within four days.
The U.S. company says the treatment could be available months before the coronavirus vaccine hits the market and notes that the STI-1499 antibody can provide “100% inhibition” against covid-19.
Dr. Henry Ji, founder and CEO of Sorrento Therapeutics, told Fox News. “We want to emphasize there is a cure. There is a solution that works 100 percent. If we have the neutralizing antibody in your body, you don’t need the social distancing. You can open up a society without fear.”
“When the antibody prevents a virus from entering a human cell, the virus cannot survive,” Dr. Ji said. “If they cannot get into the cell, they cannot replicate. So it means that if we prevent the virus from getting the cell, the virus eventually dies out. The body clears out that virus.”
Ji also noted that the antibody can be used as preventive therapy, since there are no side effects, and it may be more effective than any vaccine that may be developed in the future.
Sorrento Therapeutics has partnered with the Mount Sinai Hospital Network, (New York), to develop an antibody cocktail. “Covi-Shield”, as it is nicknamed, will be compo
sed of three different antibodies, which
target different parts of the virus, and is pending approval by the Food and Drug Administration (FDA).
In the case that authorization is obtained, it will be used as a prophylactic treatment for those who have been exposed to the virus.